Viking Therapeutics VKTX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's operating lease liabilities (current)?
- Viking Therapeutics (VKTX) reported operating lease liabilities (current) of $0 in Q1 2026.
- How has Viking Therapeutics's operating lease liabilities (current) changed year-over-year?
- Viking Therapeutics's operating lease liabilities (current) decreased by 100.0% year-over-year, from $498K to $0.
- What is the long-term trend for Viking Therapeutics's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Viking Therapeutics's operating lease liabilities (current) has grown at a -16.1% compound annual growth rate (CAGR), from $330K to $137K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.